Opal Wealth Advisors, LLC Astrazeneca PLC Transaction History
Opal Wealth Advisors, LLC
- $315 Million
- Q3 2024
A detailed history of Opal Wealth Advisors, LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Opal Wealth Advisors, LLC holds 4,916 shares of AZN stock, worth $310,838. This represents 0.12% of its overall portfolio holdings.
Number of Shares
4,916
Previous 2,502
96.48%
Holding current value
$310,838
Previous $195,000
96.41%
% of portfolio
0.12%
Previous 0.06%
Shares
2 transactions
Others Institutions Holding AZN
# of Institutions
1,356Shares Held
475MCall Options Held
5.14MPut Options Held
3.06M-
Price T Rowe Associates Inc Baltimore, MD62.9MShares$3.98 Billion0.56% of portfolio
-
Primecap Management CO Pasadena, CA42MShares$2.65 Billion2.45% of portfolio
-
Wellington Management Group LLP Boston, MA37.2MShares$2.36 Billion0.52% of portfolio
-
Capital International Investors Los Angeles, CA36.8MShares$2.33 Billion0.57% of portfolio
-
Franklin Resources Inc San Mateo, CA19.3MShares$1.22 Billion0.43% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $196B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...